PTC Therapeutics (PTCT) Stock Price
$47.39 0%
to add to portfolio
AI Score
-
Alternative
3 -
Fundamental
2 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on PTC Therapeutics, AI stock picks, stock alerts and much more.
PTCT AI Stock Analysis
AI stock analysis for PTCT is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like PTC Therapeutics (PTCT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
PTC Therapeutics (PTCT) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of PTC Therapeutics (PTCT), currently trading at $47.39, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About PTCT
-
PTC Therapeutics, Inc.
-
Symbol
PTCT
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
3.7B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.52 1.5% |
5 |
 |
Inovio Pharmaceuticals INO |
$1.74 1.2% |
1 |
 |
Moderna MRNA |
$24.72 1.9% |
3 |
 |
Anavex Life Sciences AVXL |
$8.95 1.2% |
5 |
 |
BridgeBio Pharma BBIO |
$33.87 0.1% |
4 |
News
PTCT Alternative Data
Web Traffic
PTC Therapeutics receives an estimated 21051 monthly visitors to ptcbio.com.
-
Web Traffic
21051
-
Change from Previous Month
30.3%
-
3 Month Change
25.7%
-
YoY Change
25.7%
News Mentions
PTC Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
Reddit Mentions
PTC Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
Twitter Followers
PTC Therapeutics has 2,320 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.4% over the last month.
-
Twitter Followers
2320
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Facebook Engagement
PTC Therapeutics has engaged 17 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
17
-
Daily Change
6.3%
-
1 Month Change
43.3%
-
3 Month Change
240%
-
YoY Change
240%
Job Postings
PTC Therapeutics currenly has an estimated 52 open job postings, up by 2% over the last month.
-
Job Postings
52
-
Daily Change
0%
-
1 Month Change
2%
-
3 Month Change
67.7%
-
YoY Change
67.7%
Instagram Followers
PTC Therapeutics has 3,566 Instagram Followers on its main Instagram account, up by 1% over the last month.
-
Instagram Followers
3566
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
3.2%
-
YoY Change
3.2%
LinkedIn Employees
According to LinkedIn, PTC Therapeutics has 1,144 employees.
-
LinkedIn Employees
1144
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.1%
-
YoY Change
0.1%
Business Outlook
According to employee reviews, the business outlook among employees at PTC Therapeutics is 51 out of 100 (neutral).
-
Business Outlook
51
-
Change from Previous Month
1.9%
-
3 Month Change
0%
-
YoY Change
0%
PTCT Financials
PTCT Key Metrics
-
Total Revenue
$213.2M
-
Net Income
-$65.9M
-
Earnings per Share
-$0.86
-
Free cash flow
-$36.5M
-
EBITDA
-$46.9M
-
EBITDA Ratio
-0.219893
-
Total Assets
$1.7B
PTCT 2-year Revenue & Income
PTCT 2-year Free Cash Flow
PTCT Technicals
PTCT SMA
PTCT RSI
FAQ
What's the current price of PTC Therapeutics (PTCT) Stock?
The price of an PTC Therapeutics (PTCT) share is $47.39.
What's the market cap of PTC Therapeutics?
The current market cap of PTC Therapeutics is 3.7B.
Should I buy or sell PTCT?
PTC Therapeutics exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is PTC Therapeutics a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in PTC Therapeutics stock. There are several bearish signals and market challenges that could negatively impact PTC Therapeutics' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy PTC Therapeutics (PTCT) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy PTC Therapeutics stock right now, as the outlook appears bearish.
What are some stocks similar to PTC Therapeutics (PTCT) that investors often compare it to?
PTC Therapeutics (PTCT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for PTC Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast PTC Therapeutics' stock price to be around $44.09 in 2026. Starting from the current price of $47.39, this represents a 7% change in price, indicating a bearish outlook for the stock.
How to buy PTC Therapeutics (PTCT) Stock?
PTC Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy PTC Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.